Top 4 Small-Cap Stocks In The Drug Stores Industry With The Highest Revenue Estimates

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Below are the top small-cap drug stores stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.Analysts expect Rite Aid (NYSE: RAD) to post revenue of $25.36 billion for the year ending February, 2013. Rite Aid had $263.64 million in total cash for the latest quarter.PharMerica (NYSE: PMC) is likely to post revenue of $1.83 billion in the year ending December, 2012. PharMerica's trailing-twelve-month operating margin is 3.88%.BioScrip (NASDAQ: BIOS) may report revenue of $651.40 million in the current year ending December, 2012. BioScrip's trailing-twelve-month ROE is 1.61%.China Nepstar Chain Drugstore (NYSE: NPD) is expected to report revenue of $395.83 million for the current year. China Nepstar's trailing-twelve-month ROA is 1.70%.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!